[1]
2025. Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma. Archivio Italiano di Urologia e Andrologia. 97, 2 (Jun. 2025). DOI:https://doi.org/10.4081/aiua.2025.13880.